Feb 8, 2022· Comment from Association for Accessible Medicines (AAM)· FDA-2021-D-0861-0006
The Association for Accessible Medicines ("AAM") is pleased to submit these comments on FDA's draft on docket No. FDA-2021-D-0861, "Cover Letter Attachments for Controlled Correspondences and ANDA Submissions."